SCHEMBL4540473

SCHEMBL4540473

COc1ccc(Cn2cnc3c(NCCc4cc5cccc(Cl)c5c(C5CN(CC=O)CCO5)n4)ncnc32)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
MAPT P10636 2/20 0.35
HTT P42858 2/20 0.34
PDGFRA P16234 1/20 0.34
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
HPGD P15428 1/20 0.34
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
YTHDC1 Q96MU7 1/20 0.33
CTSL P07711 2/20 0.33
FGFR1 P11362 1/20 0.33
FGFR2 P21802 1/20 0.33
FGFR4 P22455 1/20 0.33
FGFR3 P22607 1/20 0.33
SLC29A1 Q99808 1/20 0.33
TMIGD3 P0DMS9 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4539397 0.81 PDE10A (0.41) HDAC1HDAC6MAPTHTTHPGD
SCHEMBL4534986 0.81 HDAC1 (0.44) HDAC1HDAC6MAPTHTTCCNE1
SCHEMBL4530549 0.80 ALDH1A1 (0.41) HDAC1HDAC6MAPTHTTHPGD
SCHEMBL4542862 0.79 HTT (0.45) HDAC1HDAC6MAPTHTTCCNE1
SCHEMBL4539184 0.78 HDAC1 (0.43) HDAC1HDAC6MAPTHTTPDGFRA
SCHEMBL4530998 0.78 HDAC1 (0.47) HDAC1HDAC6MAPTHTTCCNE1
SCHEMBL4539338 0.77 CTSL (0.47) HDAC1HDAC6MAPTHTTCCNE1
SCHEMBL4564684 0.75 HDAC1 (0.42) HDAC1HDAC6MAPTHTTHPGD
SCHEMBL4542188 0.75 HDAC1 (0.43) HDAC1HDAC6MAPTHTTPDGFRA
SCHEMBL4533401 0.75 HDAC1 (0.46) HDAC1HDAC6MAPTHTTCCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2637669-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF Infinity Pharmaceuticals, Inc. (US) 2013-09-18 EP disclosed
WO-2012064973-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2012-05-18 WO disclosed